Table 3.
*CHD | Age Groups | Absent (n = 91) |
Mild (n = 255) |
Moderate (n = 223) |
Severe (n = 88) |
p-Value |
p-Value Bonferroni Analysis |
---|---|---|---|---|---|---|---|
∆HZ, mean ± SD | ≤2 years (n = 148) | 0.22 ± 1.39 | −0.25 ± 1.91 | −0.46 ± 1.81 | −0.74 ± 1.67 | 0.279 | |
2–5 years (n = 61) | 1.08 ± 0.88 | 0.97 ± 1.06 | −0.26 ± 1.13 | 0.48 ± 0.45 | 0.0005 | Moderate vs. Mild or Absent 0.001 and 0.003 | |
>5 years (n = 448) | 0.65 ± 1.16 | 0.47 ± 1.19 | 0.27 ± 1.14 | −0.25 ± 1.47 | 0.0002 | Severe vs. other groups 0.01, <0.001 and 0.25 | |
°WZ, mean ± SD | ≤2 years (n = 148) | 0.33 ± 1.05 | −0.25 ± 1.53 | −0.39 ± 1.45 | −0.89 ± 1.77 | 0.048 | Severe vs. Absent 0.042 |
2–5 years (n = 61) | 0.49 ± 1.12 | 0.44 ± 1.22 | −0.59 ± 1.12 | −0.48 ± 0.91 | 0.0097 | Moderate vs. Mild or Absent 0.027 and 0.051 | |
>5 years (n = 448) | 0.33 ± 0.96 | 0.23 ± 1.13 | 0.08 ± 1.22 | −0.63 ± 1.36 | <0.001 | Severe vs. other groups < 0.001 | |
§WHZ, mean ± SD | ≤2 years (n = 148) | 0.43 ± 1.07 | 0.02 ± 1.45 | 0.01 ± 1.41 | −0.40 ± 1.71 | 0.289 | |
¥BMIZ, mean ± SD | 2–5 years (n = 61) | −0.34 ± 1.32 | −0.13 ± 1.11 | −0.49 ± 1.05 | −1.03 ± 1.04 | 0.379 | |
>5 years (n = 448) | 0.04 ± 1.03 | −0.02 ± 1.26 | −0.12 ± 1.32 | −0.61 ± 1.33 | 0.010 | Severe vs. absent or mild 0.049 and 0.008 |
¥BMIZ: Body-Mass-Index-for-age z-score, *CHD: Congenital Heart Disease, ∆HZ: length/height-for-age z-score, §WHZ: weight-for-height z-score, °WZ: weight-for-age z-score. In bold significant p-values are highlighted (p-value < 0.05)